Interaction Guide · Research summary

Can I take Selenium with Baloxavir Marboxil?

Review Selenium with Baloxavir Marboxil: absorption and effectiveness, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Do not take baloxavir marboxil together with selenium supplements. The product information advises avoiding coadministration but does not establish a number of hours that makes it safe.

What this answer covers

Oral baloxavir marboxil, converted to active baloxavir, with selenium-containing products. Named label avoidance is distinct from a demonstrated human salt-specific effect.

Supplement or preparation
Selenium
Medication ingredient
baloxavir marboxil

Check the exact medicine and regimen

This review concerns baloxavir marboxil, the oral medicine in XOFLUZA. The body converts it to active baloxavir, which is measured in blood studies. It is usually a single weight-based dose; tablets and suspension products must be prepared and taken according to their own instructions.

Which products the instruction covers

XOFLUZA’s instructions name calcium, iron, magnesium, selenium and zinc supplements, along with relevant antacids and laxatives. The salt or chemical form and other ingredients should be checked rather than treating every trace dietary exposure as the same dose. The label also identifies dairy and calcium-fortified drinks separately.

Animal and food findings have limits

The label reports reduced active-baloxavir exposure with calcium, aluminum, magnesium or iron in monkeys, and states that no human mineral study was conducted. A separate human food study measured exposure after the oral prodrug under meal conditions, not isolated mineral co-use. Neither establishes a human reduction percentage for this supplement.

Plan the one-time dose with the pharmacist

Baloxavir marboxil is usually given as a single weight-based dose. It may be taken with or without ordinary food, while avoiding the products specifically listed. Ask the pharmacist how to handle a necessary supplement; do not invent a two- or four-hour interval, delay treatment on your own or repeat the antiviral after accidental co-use.

Evidence and practical considerations

Absorption & effectiveness

The exact product label supports avoiding coadministration with named mineral products; the evidence does not establish a universal human effect size or rescue interval.

Exact scope
Oral baloxavir marboxil, converted to active baloxavir, with selenium-containing products. Named label avoidance is distinct from a demonstrated human salt-specific effect. with RxNorm 2099995 IN baloxavir marboxil, the oral prodrug converted to active baloxavir/baloxavir acid. Tablet and oral suspension instructions are distinguished; measured active-metabolite exposure is not unchanged prodrug exposure.
Medication form and route
Oral

What remains uncertain

  • Current named-product label precaution. Mineral study is in monkeys, not humans; selenium/zinc lack that direct animal comparison and chemical forms vary. Prodrug administration versus active-metabolite exposure explicit. No validated spacing interval.

Factors that may matter: Exact oral regimen and formulation; Booster or fixed-combination context; Mineral preparation and dosing order; Food requirements.

Research conclusion: supported with conditions · Evidence assessment: moderate

Read the supporting source summaries

Source 1: Current original prescribing information

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed the specified oral regimen.

Avoid coadministration with dairy/calcium-fortified drinks and listed mineral medicines/supplements. Monkey mineral study lowered active exposure; no human mineral study conducted.

How this applies: RxNorm 2099995 IN baloxavir marboxil, the oral prodrug converted to active baloxavir/baloxavir acid. Tablet and oral suspension instructions are distinguished; measured active-metabolite exposure is not unchanged prodrug exposure.

No numeric mineral spacing interval in exact label, no transfer of animal percentages to humans or across every chemical form. Selenium explicitly named but not in cited animal comparison.

Source 2: Original clinical research

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Healthy Japanese volunteers; food study 15 enrolled, 12 completed.

Active baloxavir-acid exposure was lower with food/before-meal conditions; generally tolerated.

How this applies: Exact reported regimen, preparation and endpoints only; other drugs or forms remain indirect.

Original body read; early formulation and dose, not an isolated mineral trial or clinical efficacy endpoint. Current label permits food except specified products.

Source 3: Medication terminology

rxnav.nlm.nih.gov · Source check Sep 10, 2026

Population: Terminology.

baloxavir marboxil is IN.

How this applies: Exact ingredient.

Not clinical evidence.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Research summary published
Article prepared
Sources checked and article drafted.

Article revision: 2d1fedfaced28ab4

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.